GlassScriptPhysician profile
Tyler Millhouse
NPI 1821762840
$2,471.42
in general payments reported to CMS, 2019-2025
19 companies · $964 in 2025
The $964 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $224 · 2024: $1,284 · 2025: $964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,199 · Education: $48.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,198.51 |
| Education | $48.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $458.83 | 2024-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $389.26 | 2022-2025 | Jardiance |
| Pfizer INC. | $289.20 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $252.17 | 2024 | Xarelto |
| Amgen INC. | $233.26 | 2024-2025 | |
| Novo Nordisk INC | $124.39 | 2025 | Ozempic |
| Biotronik INC. | $115.19 | 2025 | Biomonitor |
| Xeris Pharmaceuticals, INC. | $99.00 | 2022 | |
| Kestra Medical Technology Services, INC. | $91.52 | 2025 | Assure Wcd |
| Medtronic, INC. | $90.46 | 2024-2025 | Mycarelink, Linq II |
| Astrazeneca Pharmaceuticals LP | $84.72 | 2024 | Farxiga |
| Scpharmaceuticals INC. | $65.01 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $53.66 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $35.20 | 2025 | Camzyos |
| Abbott Laboratories | $24.32 | 2025 | Ensite Precision |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $24.18 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $13.97 | 2024 | Arcalyst |
| Tactile Systems Technology INC | $13.79 | 2024 | Flexitouch Plus, Entre Plus |
| Esperion Therapeutics, INC. | $13.29 | 2024 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Millhouse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.